BOSENTAN - AN OVERVIEW

In WHO Useful Class II patients, take into account whether or not the benefits of bosentan are enough to offset the potential risk of hepatotoxicity, which can preclude foreseeable future use as their disorder progresses.This is often an Open up Access post which permits unrestricted noncommercial use, supplied the first operate is correctly cited.